Iclusig 15 mg film-coated tablets
FCR173011/ResToP
Phase 2 small_molecule active
Quick answer
Iclusig 15 mg film-coated tablets for Chronic myelogenous leukemia is a Phase 2 program (small_molecule) at Cancer Prevention Pharma (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cancer Prevention Pharma (Ireland) Limited
- Indication
- Chronic myelogenous leukemia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active